Table 2.
STS score | EUROSCORE additive/logistic* | Ambler Score | |
---|---|---|---|
Patient characteristics | |||
Age | + | + | + |
Gender | + | + | + |
Height | + | ||
Weight | + | ||
Body mass index | + | ||
Ethnicity | + | ||
Comorbid conditions | |||
Diabetes | + | ||
Hypertension | + | + | |
Chronic lung/pulmonary disease | + | + | |
Extracardiac arteriopathy | + | + | |
Peripheral vascular disease | + | ||
Neurological dysfunction | + | + | |
Cerebrovascular accident | + | ||
Serum creatinine | + | + | + |
Dialysis-dependent renal failure | + | + | |
Immunosuppressive therapy | + | ||
Cardiac history | |||
NYHA classification | + | ||
Unstable angina | + | + | |
Recent myocardial infarction | + | + | |
Arrhythmias | + | + | |
Previous cardiac surgery | + | + | |
Previous CABG | + | ||
Previous valvular surgery | + | ||
Previous PCI | + | ||
Active endocarditis | + | + | |
Number of diseased coronary vessels | + | ||
Type and severity of valvular disease (stenosis/regurgitation, aortic/mitral) | + | ||
Haemodynamic state | |||
Systolic pulmonary pressure > 60 mmHg | + | ||
Ejection fraction | + | + | + |
Critical pre-operative state | + | ||
Cardiogenic shock | + | ||
Resuscitation | + | ||
Inotropic agents | + | ||
Intra-aortic balloon pump | + | ||
Procedure | + | + | |
Emergency | + | + | |
Surgery on thoracic aorta | + | + | |
Aortic valve surgerya | + | + | |
Mitral valve surgerya | + | + | |
Aortic and mitral valve surgerya | + | + | |
Tricuspid surgerya | + | ||
Surgery for congenital heart disease | + | ||
Rhythmologic surgery | + | ||
Concomitant CABG | + | + | |
Concomitant tricuspid valve surgery | + | + | |
Post-infarct septal rupture | + |
*The same variables are used for the additive and logistic EuroSCORE.
STS, The Society of Thoracic Surgeons; CABG, coronary artery bypass grafting; NYHA, New York Heart Association; PCI, percutaneous coronary intervention.
aIn the STS score, the type of valvular surgery (valve replacement or repair) is taken into account.